Table 1 Demographic and baseline characteristics of 69 localized scleroderma (LS) subjects and 71 healthy control subjects who were included in the plasma analysis
From: Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma
Characteristics | LS patients | Healthy controls |
|---|---|---|
(number = 69) | (number = 71) | |
number (%) | number (%) | |
Female | 46 (66.7) | 38 (54) |
Caucasian | 63 (91) | unknown |
Median (IQR) | Median (IQR) | |
Age at plasma sample in years | 12.5 (10.0 to 16.0) | 3 (2.0 to 9.0) |
Age at disease onset in years | 9 (7.0 to 11.0) | --- |
LS subtype | ||
Linear scleroderma trunk/extremity | 26 (37.7) | --- |
Linear scleroderma head (En coup de sabre / Parry Romberg Syndrome) | 14 (20.3) | --- |
Mixed morphea | 9 (13.0) | --- |
Generalized morphea | 8 (11.6) | --- |
Plaque (circumscribed superficial) morphea | 5 (7.2) | --- |
Deep (circumscribed deep) morphea | 4 (5.8) | --- |
Pansclerotic morphea | 1 (1.4) | --- |
Clinical measures of activity: | median (IQR) | |
PGA-A | 41.0 (29.0 to 62.0) | --- |
mLoSSI | 6.0 (3.0 to 13.0) | --- |